Metformin Removal From Water

Metformin is a first-line medicine used to treat type 2 diabetes and gestational diabetes. It manages blood sugar by reducing liver glucose production, limiting intestinal sugar absorption, and increasing the body’s sensitivity to its own insulin.

This disease accounts for approximately 90% of diabetes cases and affects more than 537 million people worldwide, which has been estimated to increase to 795 million by 2045.

The consequences of allowing Metformin to accumulate in wastewater should be concerning to everyone. Primarily, it can lead to aquatic toxicity, affecting fish and other organisms. Prolonged exposure can also disrupt reproductive systems and lead to population declines in species.

Secondly, as Metformin is persistent, it causes severe endocrine disruption and other adverse effects on aquatic biota.

The presence of Metformin in wastewater poses multifaceted concerns, encompassing ecological integrity, potential human health risks, and regulatory challenges. Previous studies have demonstrated that Metformin can induce endocrine disruption and adversely affect reproductive systems in aquatic organisms. In addition, concerns remain about the potential for bioaccumulation and biomagnification of Metformin and its metabolites in aquatic food chains, with implications for human exposure, as high concentrations can cause diseases such as lactic acidosis and vitamin B12 insufficiency. Given its high production volume and widespread use, this drug may pose problems for water treatment in the future.

Metformin in manufacturing wastewater is an emerging environmental concern. Since pharmaceutical facilities discharge process water rich in the active ingredient, highly concentrated untreated effluent can reach aquatic systems. Metformin is extremely water-soluble, hydrophilic, and difficult to remove using conventional biological or coagulation methods. Metformin is increasingly recognised as a contaminant of concern due to its potential environmental and health impacts.

The removal from wastewater of products like Metformin, is crucial for protecting public health and the environment.

Chronic exposure to trace amounts of Metformin in rivers and streams is known to cause toxicity and endocrine disruption in aquatic life, thereby posing significant threats to aquatic ecosystems.

Arvia Technology stands at the forefront of wastewater treatment innovation, offering next-generation solutions like Nyex™ Ellenox to address the challenges posed by pharmaceutical contaminants in wastewater.
By prioritising the removal of these pollutants, we can protect our water resources and promote a healthier environment for future generations.

To discuss your organisation’s water treatment requirements with one of our scientists, use the form below to set up a no-obligation meeting soon.